It had already been observed that the lymphoblasts progenitors, identified by very low SSC & dim to negative CD45 expression in the CD45 versus SSC plot appeared to be reduced in patients with MDS, and in absence of CD19/CD10 in our panel, this parameter could not be evaluated. This evidence concerns the gene CD19 and myelodysplastic syndrome.